| Not Yet Recruiting | A Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate Cancer Prostate Cancer | Phase 1 | 2026-04-30 |
| Not Yet Recruiting | Evaluate the Efficacy and Safety of GZR18 Injection in Obese Subjects With Obstructive Sleep Apnea Not Treated Obstructive Sleep Apnea (OSA) | Phase 3 | 2026-04-27 |
| Not Yet Recruiting | Evaluate the Efficacy and Safety of GZR101-80 Injection in Patients With Type 2 Diabetes Type 2 Diabetes (T2DM) | Phase 2 | 2026-04-10 |
| Not Yet Recruiting | Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 Diabetes Type 2 Diabetes (T2DM) | Phase 3 | 2026-04-07 |
| Not Yet Recruiting | Evaluate the Efficacy and Safety of GZR18 Injection in Obese Subjects With Obstructive Sleep Apnea Receiving P Obstructive Sleep Apnea (OSA) | Phase 3 | 2026-03-27 |
| Not Yet Recruiting | A Study to Evaluate the Biosimilarity of GLR1044 Injection and Dupilumab Injection (Dupixent®) in Healthy Adul Biosimilarity | Phase 1 | 2026-03-09 |
| Recruiting | Extension Study of the Phase 3 Clinical Study of GZR18 Injection for Weight Loss Overweight or Obesity | Phase 3 | 2026-01-22 |
| Recruiting | Bioequivalence Study of GZR18 Injection Before and After CMC Change Obesity&T2D | Phase 1 | 2026-01-09 |
| Recruiting | Study on Gastric Emptying Effect and Drug-Drug Interactions of GZR18 Injection Obesity or Overweight | Phase 1 | 2025-11-17 |
| Active Not Recruiting | Pharmacokinetic and Safety Study of GZR4 Injection in Subjects With Hepatic Impairment Diabetes | Phase 1 | 2025-10-20 |
| Recruiting | A Phase IIIb Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitu Diabetes | Phase 3 | 2025-10-17 |
| Recruiting | Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adu Obesity/Overweight in Adult | Phase 3 | 2025-09-23 |
| Recruiting | Study of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Liver Insufficiency and Normal Liver Obesity/Overweight | Phase 1 | 2025-08-12 |
| Active Not Recruiting | A Study to Compare the Efficacy and Safety of GZR102 Injection and GZR18 Injection in Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus (T2DM) | Phase 2 | 2025-08-07 |
| Not Yet Recruiting | A Phase I Study to Evaluate the PK and PD Profiles of GZR102 Injection Versus GZR4 Injection and GZR18 Injecti Type 2 Diabetes | Phase 1 | 2025-05-08 |
| Completed | The Study of [14C] GZR18 Overweight, Obese, Obesity | Phase 1 | 2025-05-07 |
| Recruiting | Study of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Renal Impairment and Normal Renal Fun Obesity/Overweight | Phase 1 | 2025-04-11 |
| Active Not Recruiting | A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Type 2 Diabetes Mellitus Subjects (T2D Diabetes | Phase 3 | 2025-02-18 |
| Active Not Recruiting | A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Insulin-naive Subjects With Type 2 Dia Diabetes | Phase 3 | 2025-02-17 |
| Active Not Recruiting | A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Diabetes | Phase 3 | 2025-02-15 |
| Active Not Recruiting | A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes Mel Type 2 Diabetes Mellitus (T2DM) | Phase 3 | 2025-02-13 |
| Active Not Recruiting | A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Subjects With Type 2 Diab Type 2 Diabetes Mellitus (T2DM) | Phase 3 | 2025-01-16 |
| Active Not Recruiting | A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Obese/Overweight Su Obesity/Overweight | Phase 3 | 2024-12-30 |
| Recruiting | A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid Primary Hyperlipidemia | Phase 3 | 2024-12-20 |